Avoiding hyperoxia in infants < or = 1250 g is associated with improved short- and long-term outcomes

R Deulofeut1, A Critz, I Adams-Chapman

  • 1Division of Neonatal-Perinatal Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Insights

Avoiding hyperoxia in premature infants significantly reduced neonatal complications. This practice change did not negatively impact developmental outcomes at 18 months corrected age, showing improved long-term health for very low birth weight infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Critical Care
  • Perinatal Research

Background:

  • Hyperoxia, or excessive oxygen exposure, is a concern in neonatal intensive care.
  • Clinical practice guidelines aim to optimize oxygen saturation (SpO2) in preterm infants.
  • Previous practices may have led to unintended hyperoxia in vulnerable neonates.

Purpose of the Study:

  • To evaluate the impact of a clinical practice change designed to avoid hyperoxia.
  • To compare short- and long-term morbidity in very low birth weight infants before and after the intervention.
  • To assess the effect of avoiding hyperoxia on neurodevelopmental outcomes.

Main Methods:

  • Analysis of a prospectively collected database of infants weighing <= 1250g.
  • Comparison of two periods: before (Period I) and after (Period II) a change in SpO2 target ranges (85-93%).
  • Statistical analysis included bivariate and multivariate logistic regression to compare outcomes.

Main Results:

  • Infants in Period II (post-intervention) showed significantly lower rates of retinopathy of prematurity, supplemental oxygen use at 36 weeks, and steroid use for chronic lung disease.
  • No significant differences were observed in rates of necrotizing enterocolitis, intraventricular hemorrhage, or periventricular leukomalacia.
  • At 18 months corrected age, infants from Period II had higher Mental Developmental Index scores, with similar Psychomotor Developmental Index scores compared to Period I.

Conclusions:

  • A clinical practice change to avoid hyperoxia in preterm infants is associated with reduced neonatal morbidity.
  • This practice change did not adversely affect neurodevelopmental outcomes at 18 months corrected age.
  • Optimizing oxygen management in very low birth weight infants can improve neonatal outcomes without compromising long-term development.
Abstract

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...